The evolution of rectal cancer treatment led to the development of different techniques and technologies to perform the colorrectal anastomosis. The mechanical staplers constituted, some decades ago, a breakpoint in rectal treatment; however, the introduction of transanal-transabdominal TME has led us to modify some of the conventional steps and instruments used previously to adapt to the new technique. In this next video, we will show different types of mechanical and hand sewn anastomosis which it would be useful to know how to perform in the different situations during the TaTME procedure.

The Transanal Total Mesorectal Excision is an innovative approach for rectal cancer. It provides several advantages compared to the fully laparoscopic technique.  With this procedure, issues like transection of the distal margin and difficult cases may have found a solution.

In this video Dr. Berends discusses the impact of biliopancreatic limb length on weight loss when performing a Roux-en-Y gastric bypass for morbidly obese patients, according to the results of his randomized trial, the Elegance Trial.

We were delighted to welcome Professor Johan Askling, Karolinska Institutet, to our meeting in Nice to discuss the role of big data in surgical practice.

In this lecture, Jan J. De Waele explains how different antimicrobial resistances are produced and how this problem can be improved by integrating antimicrobial stewardship strategies in clinical practice, upholding the best antibiotic empirical therapy while reducing antibiotic consumption.

In this excellent presentation, Abdelrahman A. Nimeri reviews the concepts of weight loss and the long-term consequences of the most common bariatric procedures. He also explains the currents trends in the treatment of superobese patients.

ESCP were delighted to host a joint session with EHTG (European Hereditary Tumour Group) on hereditary colorectal cancer. Part of this session saw Matthias Kloor present on ‘SI, HNPCC, Lynch syndrome and immunotherapy including vaccine: an update’

Details of neoadjuvant treatment in esophageal cancer: why, when, and how to use it? We will go into the details of big trials such as the FLOT and CROSS studies. Finally, we will discuss the new drugs and the importance of targeted therapies.

The rise in the demand for liver donors in end-stage liver disease has led to a search for new sources, such as the non-heart beating donation or donation after cardiac arrest. Its importance has been growing in the last decades and it now is a significant source of organs along with the donation after brain death. We briefly review the main characteristics of this type of donation.